Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bumi Resources Tbk (BUMI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bumi Resources TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Bumi Resources Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bumi Resources Tbk trades at Rp150 (market cap 54.96T, 878.29M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp250 (market cap 167.37B, 42.8K 24h volume). The key difference: Bumi Resources Tbk is far larger — about 328.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bumi Resources Tbk is more actively traded (878.29M versus 42.8K). Which is the better fit depends on your goals.

BUMIOBAT
Market Cap
54.96T167.37B
Volume
878.29M42.8K
Lot
8.78M428
Turnover
131.34B10.55M
Average Price
149.54246.48
Value
131.34B10.55M
Indicative Equilibrium Price
148246
Indicative Equilibrium Volume
13.08M2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BUMI
View details
OBAT
View details

About Bumi Resources Tbk

PT Bumi Resources Tbk was established in the Republic of Indonesia on June 26, 1973 based on Notarial Deed No. 130 and No. 103 dated Novmeber 28, 1973, both made by Djoko Soepadmo, S.H., notary in Surabaya. PT. Bumi Resources Tbk, previously named PT. Bumi Modern Tbk. (Company) is a Domestic Investment Company (PMDN), initially engaged in hotel and tourism industry. The Company has carried out diversification of activities expected to improve optimal return for shareholders. The Company deems it necessary to change the previous business activities, namely Hotel and Tourism Industries to Oil and Natural Gas Mining Industries.

Read more on BUMI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT